Community Prevention Unit


Prof F. Paccaud


This unit is active in disease prevention, mainly in the field of cardiovascular disease and epidemiological transition (with a group active in the Seychelles since about 20 years), in close collaboration with the World Health Organization (IUMSP as collaborating centre) and other international organizations.


Bovet P, Ross AG, Gervasoni JP, et al. Distribution of blood pressure, body mass index and smoking habits in the urban population of Dar es Salam, Tanzania, and associations with socio-economic status. Int J Epidemiol 2002;31:240-7.

Stettler N, Bovet P, Shamlaye H, et al. Prevalence and risk factors for overweight in children from Seychelles, a country in rapid transition: the importance of early growth. Int J Obesity 2002;26:214-9.

Lemogoum D, Seedat YK, Mabadeje AFB, et al. Recommendations for diagnosis and management of hypertension in sub-Saharan Africa. J Hypertens 2003;21:1993-2000.

Bochud M, Eap CB, Elston RC, et al. Association of CYP3A5 genotypes with blood pressure and renal function in African families. J Hypertens 2006;24:923-9.

Cornuz J, Gilbert A, Pinget C, et al. Cost-effectiveness of pharmacotherapies for nicotine dependence in primary care setting ? a multinational comparison. Tob Control 2006;15(3):152-9.

Rodondi N, Humair JP, Ghali WA, et al. Counseling overweight and obese patients in primary care: a prospective study. Eur J Cardiovasc Prev Rehabil 2006;13:222-8.

Cardiovascular disease and epidemiological transition (GCT)


The following files can be downloaded (right click on the filename):

File Description
Panel-fr.pdf Désaccoutumance au tabac en Suisse
Panel-de.pdf Tabakentwöhnung in der Schweiz.
markovmodel.pdf Markov Model for the Lausanne University Cost-effectiveness Analyses on Smoking Cessation Interventions
EUhosp_quest.pdf Questionaire on smoking cessation conselling for inpatients in some european hospitals
EUhosp_data.pdf Smoking cessation conselling availability in some european hospitals.
b_cas_res.xls Table: Synthesis of cost-effectiveness ratios for a 45-year-old.
b_cas_res_age.xls Table: Incremental cost-effectiveness ratios by age.
sa_trt_eff.xls Table: Sensitivity Analysis - Treatment Efficacy.
sa_rel_1_Tx.xls Table: Sensitivity Analysis - Relapse during 1st month of treatment.
sa_rel_2_Tx.xls Table: Sensitivity Analysis - Relapse during 2nd month of treatment.
sa_prop_smo.xls Table: Sensitivity Analysis - Proportion of smokers in "preparation" stage.
sa_nat_cess_rate.xls Table: Sensitivity Analysis - Natural cessation rate.
sa_life_rel_rate.xls Table: Sensitivity Analysis - Lifetime relapse rate.
patch_sa_Tx_price.xls Figure: Sensitivity Analysis - Patch and Price.
patch_sa_Tx_eff.xls Figure: Sensitivity Analysis - Patch and Efficacy.
patch_sa_GP_fees.xls Figure: Sensitivity Analysis - Patch and GP fees.